Is human T cell lymphotropic type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) syndrome a neglected disease?

PLoS Neglected Tropical Diseases

Volumn 3, Issue 11, 2009, Pages

  Casseb, Jorge ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE;

CASE STUDY; CLINICAL FEATURE; CLINICAL PRACTICE; CONSTIPATION; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG PULSE THERAPY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LOW BACK PAIN; PARESTHESIA; PROFESSIONAL KNOWLEDGE; REVIEW; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; TREATMENT DURATION; ADULT; ARTICLE; CASE REPORT; FEMALE; TROPICAL MEDICINE; TROPICAL SPASTIC PARAPARESIS; VIROLOGY;

ADULT; FEMALE; HTLV-I INFECTIONS; HUMANS; PARAPARESIS, TROPICAL SPASTIC; TROPICAL MEDICINE;

EID: 73449124062     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000487     Document Type: Review

References (22)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, et al. (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. ProcNatl Acad Sci U S A 77: 7415-7419.
2. Gallo RC (2005) History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2. Oncogene 24: 5926-5930.
3. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL (2005) Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24: 6058-6068.
4. Edlich RF, Hill LG, Williams FM (2003) Global epidemic of human T-cell lymphotrophic virus type-I (HTLV-I): an update. J Long Term Eff Med Implants 13: 127-140.
5. Matsuoka M (2005) Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL). Retrovirology 2: 27-40.
6. Romn GC, Román LN, Spencer PS, Schoenberg BS (1985) Tropical spastic paraparesis: a neuroepidemiological study in Colombia. Ann Neurol 17: 361-365.
7. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, et al. (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2: 407-410.
8. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, et al. (1986) HTLV-I associated myelopathy, a new clinical entity. Lancet 1: 1031-1032.
9. Rodgers-Johnson P, Gajdusek DC, Morgan OS, Zaninovic V, Sarin PS, et al. (1985) HTLV-I and HTLV-III antibodies and tropical spastic paraparesis. Lancet 2: 1247-1248.
10. Kaplan JE, Osame M, Kubota H, Igata A, Nishitani H, et al. (1990) The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 3: 1096-1101.
11. Gotuzzo E, Cabrera J, Deza L, Verdonck K, Vandamme AM, et al. (2004) Clinical characteristics of patients in Peru with human T cell lymphotropic virus type 1-associated tropical spastic paraparesis. Clin Infect Dis 39: 939-944.
12. Gessain A, Gout O (1992) Chonic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann Int Med 117: 933-946.
13. Verdonck K, González E, Van Dooren S, Vandamme AM, Vanham G, et al. (2007) Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 7: 266-281.
14. De Castro-Costa CM, Araújo AQ, Barreto MM, Takayanagui OM, Sohler MP, et al. (2006) Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). AIDS Res Hum Retroviruses 22: 931-935.
15. Matsuzaki T, Nakagawa M, Nagai M, Usuku K, Higuchi I, et al. (2001) HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years. J Neurovirol 7: 228-234.
16. Carod-Artal FJ, Mesquita HM, Ribeiro LS (2008) Neurological symptoms and disability in HTLV-1 associated myelopathy. Neurologia 23: 78-84.
17. Araújo AQ, Afonso CR, Leite AC, Dultra SV (1993) Intravenous methylprednisolone in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP). Arq Neuropsiquiatr 51: 325-328.
18. Centers for Disease Control and Prevention and U.S. Public Health Service Working Group (1993) Recommendations for counseling persons infected with human T-lymphotrophic virus, types I and II. MMWR Recomm Rep 42(RR-9): 1-13.
19. Ministério da Saúde do Brasil: Grupo de Trabalho em HTLV (2003) Cartilha contendo informações básicas sobre HTLV para distribuic ̧ão na rede Pública de Saúde, Brasília, Brasil.
20. Carod-Artal FJ (2009) Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus. Rev Neurol 48: 147-155.
21. Lezin A, Gillet N, Olindo S, Signaté A, Grandvaux N, et al. (2007) Histone deacetylase mediated transcriptional activation reduces proviral loads in HTLV-1 associated myelopathy/tropical spastic paraparesis patients. Blood 110: 3722-3728.
22. Croda MG, Oliveira ACP, Vergara MPP, Bonasser F, Smid J, et al. (2008) Corticosteroid therapy in TSP/HAM patients: the results from a 10 years open cohort. J Neurol Sci 269: 133-137.